Canada Markets open in 7 hrs 55 mins

Small Pharma Inc. (DMTTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1061-0.0199 (-15.79%)
At close: 12:41PM EST

Small Pharma Inc.

6-8 Bonhill Street
3rd Floor
London EC2A 4BX
United Kingdom

https://www.smallpharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. George TzirasCEO & Non-Independent Director275.48kN/AN/A
Mr. Peter David RandsChief Innovation & Intellectual Property Officer, Founder and Director324.02kN/AN/A
Mr. David SteelChief Financial Officer268.88kN/AN/A
Dr. Carol RoutledgeChief Scientific & Medical Officer336.4kN/AN/A
Ms. Marie Claire LayzellChief Manufacturing & Devel. Officer & Director317.82kN/AN/A
Dr. Alastair James Riddell M.D., M.Sc., MBChB, MFPM, MRCGP, MSc, Ph.D.Chief Operating OfficerN/AN/A1949
Ms. Jenny MaguireHead of Brand & CommunicationsN/AN/AN/A
Ms. Emma HodgeHead of Intellectual PropertyN/AN/AN/A
Mr. Richard M. Kimel HBA, LLBCorp. Sec.N/AN/A1967
Ms. Sarah HamiltonGroup Financial ControllerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.

Corporate Governance

Small Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.